Literature DB >> 30409308

The transcriptional co-activator YAP: A new player in head and neck cancer.

Carmen Segrelles1, Jesús M Paramio1, Corina Lorz2.   

Abstract

The Hippo-YAP (Yes-associated protein) pathway is a key regulator of tissue growth, organ size and stem cell function. More recently, a fundamental role for this pathway has emerged in stem cell function and tumorigenesis. Activation of the transcriptional co-activator YAP promotes cell-contact independent proliferation, epithelial to mesenchymal transition (EMT), cancer stem cell features and drug resistance. In this review, we describe the main components of the pathway, the microenvironment and the cell-intrinsic cues governing its activation, the downstream players of the pathway and the biological implications of their activation in the context of cancer. We will focus on the existing knowledge of this pathway in head and neck squamous carcinoma (HNSCC), its clinical value in this type of cancer as a marker of poor prognosis and resistance to therapy, as well as the most encouraging therapeutic strategies targeting the pathway.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cell growth; Cell proliferation; Head and neck cancer; Hippo pathway; TAZ; YAP; YAP inhibitors

Year:  2018        PMID: 30409308     DOI: 10.1016/j.oraloncology.2018.08.020

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  13 in total

Review 1.  Recent Advances of the Hippo/YAP Signaling Pathway in Brain Development and Glioma.

Authors:  Taohui Ouyang; Wei Meng; Meihua Li; Tao Hong; Na Zhang
Journal:  Cell Mol Neurobiol       Date:  2019-11-25       Impact factor: 5.046

2.  Stress-triggered YAP1/SOX2 activation transcriptionally reprograms head and neck squamous cell carcinoma for the acquisition of stemness.

Authors:  Hirofumi Omori; Kuniaki Sato; Takafumi Nakano; Takahiro Wakasaki; Satoshi Toh; Kenichi Taguchi; Takashi Nakagawa; Muneyuki Masuda
Journal:  J Cancer Res Clin Oncol       Date:  2019-09-04       Impact factor: 4.553

3.  Effects of YAP1 and SFRP2 overexpression on the biological behavior of colorectal cancer cells and their molecular mechanisms.

Authors:  Zhenzhen Bai; Qingqing Wu; Cong Zhang; Jing Chen; Liyu Cao
Journal:  J Gastrointest Oncol       Date:  2021-08

Review 4.  The deadly cross-talk between Hippo pathway and epithelial-mesenchymal transition (EMT) in cancer.

Authors:  Ioanna Akrida; Vasiliki Bravou; Helen Papadaki
Journal:  Mol Biol Rep       Date:  2022-05-23       Impact factor: 2.742

Review 5.  NSAID therapy for PIK3CA-Altered colorectal, breast, and head and neck cancer.

Authors:  Yi Cai; Andrew Yousef; Jennifer R Grandis; Daniel E Johnson
Journal:  Adv Biol Regul       Date:  2019-09-15

6.  Activated hippo signal pathway inhibits cell proliferation and promotes apoptosis in NK/T cell lymphoma cells.

Authors:  Yu Chang; Xiao-Rui Fu; Meng Cui; Wei-Ming Li; Lei Zhang; Xin Li; Ling Li; Zhen-Chang Sun; Xu-Dong Zhang; Zhao-Ming Li; Xiao-Yan You; Fei-Fei Nan; Jing-Jing Wu; Xin-Hua Wang; Ming-Zhi Zhang
Journal:  Cancer Med       Date:  2019-05-23       Impact factor: 4.452

Review 7.  Hippo Pathway and YAP Signaling Alterations in Squamous Cancer of the Head and Neck.

Authors:  Karla Santos-de-Frutos; Carmen Segrelles; Corina Lorz
Journal:  J Clin Med       Date:  2019-12-03       Impact factor: 4.241

8.  The crosstalk between AXL and YAP promotes tumor progression through STAT3 activation in head and neck squamous cell carcinoma.

Authors:  Jiayi Li; Chaoji Shi; Rong Zhou; Yong Han; Shengming Xu; Hailong Ma; Zhiyuan Zhang
Journal:  Cancer Sci       Date:  2020-07-16       Impact factor: 6.716

Review 9.  Precision Medicine Gains Momentum: Novel 3D Models and Stem Cell-Based Approaches in Head and Neck Cancer.

Authors:  Annette Affolter; Anne Lammert; Johann Kern; Claudia Scherl; Nicole Rotter
Journal:  Front Cell Dev Biol       Date:  2021-07-08

10.  Clostridium perfringens enterotoxin induces claudin-4 to activate YAP in oral squamous cell carcinomas.

Authors:  Chie Nakashima; Kazuhiko Yamamoto; Shingo Kishi; Takamitsu Sasaki; Hitoshi Ohmori; Rina Fujiwara-Tani; Shiori Mori; Isao Kawahara; Yukiko Nishiguchi; Takuya Mori; Masuo Kondoh; Yi Luo; Tadaaki Kirita; Hiroki Kuniyasu
Journal:  Oncotarget       Date:  2020-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.